Table 1.
Demographic, comorbidity, medications, and clinical metrics in the ICH, ischemic stroke, and myocardial infarction datasets
| Measure | ICH | P value | Ischemic stroke | P value | Myocardial infarction | P value | |||
|---|---|---|---|---|---|---|---|---|---|
| Pre-AI (N = 289) | Post-AI (N = 298) | Pre-AI (N = 608) | Post-AI (N = 1126) | Pre-AI (N = 217) | Post-AI (N = 160) | ||||
| Age, year mean (SE) |
71.1 (0.88) |
68.7 (0.95) |
0.062 |
71.3 (0.52) |
71.2 (0.4) |
0.78 |
65.4 (0.89) |
66.4 (1.1) |
0.5 |
| Man, % (SE%) | 58.5% (2.9%) | 62.8% (2.8%) | 0.32 | 53.4% (2%) | 54.5% (1.4%) | 0.71 | 80.6% (2.7%) | 69.3% (3.6%) | 0.02 |
| Smokers, % (SE%) | 5.8% (1.4%) |
5.7% (1.3%) |
1 | 5.2% (0.9%) |
7% (0.7%) |
0.18 |
9.6% (2%) |
11.8% (2.5%) | 0.61 |
| Diabetes Mellitus, % (SE%) | 15.2% (2.1%) |
12.7% (2%) |
0.45 | 17.7% (1.5%) | 20.7% (1.2%) | 0.15 | 20.7% (2.7%) | 17.5% (3%) | 0.5 |
| Hypertension, % (SE%) | 26.9% (2.6%) | 26.9% (2.6%) | 0.37 | 36% (1.9%) | 34.5% (1.4%) | 0.57 | 30.8% (3.1%) | 26.8% (3.5%) | 0.46 |
| Chronic heart failure, % (SE%) | 4.5% (1.2%) |
4.5% (1.2%) |
0.76 |
5.9% (1%) |
4.8% (0.6%) | 0.42 | 4.6% (1.4%) | 5.6% (1.8%) | 0.83 |
|
Anticoagulation and anti-aggregation agents, % (SE%) |
41.8% (3.0%) | 28.8% (2.6%) | 0.001 | 53.4% (2.0%) | 35.2% (1.4%) | < 0.001 | 52.1% (3.4%) | 28.7% (3.6%) | < 0.001 |
| Hypertensive agents, % (SE%) | 8.3% (1.6%) |
6.1% (1.4%) |
0.36 | 5.4% (0.9%) | 4.5% (0.6%) | 0.47 | 4.1% (1.3%) | 1.8% (1.0%) | 0.34 |
| White blood count median (IQR) |
9.6 (7.5–12.6) |
9.9 (7.8–12.9) |
0.42 |
8.2 (6.7–9.9) |
7.9 (6.5–9.8) |
0.22 |
11.1 (8.9–13.8) |
10.9 (9.1–13.6) |
0.58 |
| Hemoglobin count median (IQR) |
12.9 (11.8–14.3) |
13.3 (12.1–14.7) |
0.007 |
13.4 (12.3–14.4) |
13.4 (12.4–14.5) |
0.37 |
14.2 (12.8–15.3) |
14.2 (13–15.3) |
0.76 |
| Platelet count median (IQR) |
216 (179–263) |
230 (190–276) |
0.009 |
226 (188–264) |
228 (188–271) |
0.28 |
233 (194–277) |
254 (207–260) |
0.01 |
| CT-TAT |
8.24 (7.41) |
7.2 (6.49) |
0.07 | –- | –- | –- | –- | ||
| Emergency Severity Index 103, % (SE%) | 54.4% (2.9%) | 61.7% (2.8%) | 0.13 | 81.4% (1.5%) | 78.7% (1.2%) | 0.12 | 44.7% (3.3%) | 60.0% (3.8%) | 0.57 |
| Length of stay, days mean (SE) |
19.5 (2.8) |
18.0 (1.7) |
0.193 |
6.9 (0.7) |
8.6 (0.54) |
0.002 |
6.2 (0.54) |
5.4 (0.51) |
0.221 |
| Mortality after 30 days, % (SE%) | 27.7% (2.9%) | 17.5% (2.3%) | 0.004 | 2.4% (0.06%) | 3.6% (0.5%) | 0.33 | 7.0% (1.8%) | 11.0% (2.5%) | 0.550 |
| Mortality after 30 days, % change | − 36.8% | 50% | 57.1% | ||||||
| Mortality after 120 days, % (SE%) | 31.8% (2.9%) | 21.7% (2.4%) | 0.017 | 4.9% (0.9%) | 6.0% (0.7%) | 0.50 | 8.0% (1.9%) | 14.5% (2.8%) | 0.170 |
| Mortality after 120 days, % change | − 31.7% | 22.4% | 81.2% | ||||||
| Modified Ranking Scale baseline | 0.76 (1.309) | 0.77 (1.243) | 0.944 | –- | –- | –- | –- | ||
| Modified Ranking Scale Discharge | 3.17 (2.193) | 2.84 (1.911) | 0.044 | –- | –- | –- | –- | ||
| Modified Ranking Scale difference discharge, baseline | 2.37 (2.219) | 2.03 (1.951) | 0.041 | –- | –- | –- | –- | ||
SE standard error, IQR interquartile range